Kim et al. analyzed the circulating CD8+ T cells from patients with locally advanced NSCLC and found that the proliferation of circulating CD8+ T cells and relative frequency of CD39+ tumor-specific cells among circulating CD8+ T cells were increased by concurrent chemoradiotherapy (CCRT) [38]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.